By Rajasik Mukherjee April 23 (Reuters) - Australian biotech giant CSL extended losses on Thursday, lingering near decade ...

CSL shares hit a 9-year low as new demand concerns emerge. The post CSL's collapse deepens. Why this ASX giant can't find a ...

A casual enthusiast might tell you that BMW’s M-badged models are the company’s peak performance offerings. The true fans know that in reality, the rare CSL models are a cut above. In its latest video ...

CSL shares are tumbling again on Wednesday. Here's what it'll take for the price to take a u-turn. The post Prediction: CSL ...

Earlier this year, BMW debuted the M4 CS, a car designed to sit between the Competition Package and the ultra-hardcore M4 GTS. Of course, bringing back the CS designation, which stands for Coupe Sport ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...

Robert has been an auto enthusiast his entire life. He started working on cars at a young age, learning the basics from his father in the home garage on the weekends. Over the years, he learned as ...

Five years ago, Frank van Meel, head of BMW M, revealed to Road & Track that it's bringing back the legendary CSL nameplate. Today, BMW announced that the long-anticipated M4 CSL will finally make its ...

An announcement from CSL ( (AU:CSL)) is now available. CSL Limited says the U.S. administration’s planned Section 232 tariffs on imported pharmaceuticals are expected to have limited impact on its U.S ...